Close
Achema middle east
swop processing & packaging

Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

New Tariff Announcement by Trump for Pharma, Patented Drugs

The announcement made by President Donald Trump that his...

U.S. Tariff Relief for EU and Japan on Pharmaceuticals

Donald Trump’s new tariffs when it comes to pharmaceutical...

Five key considerations for biotechs outsourcing biologics manufacturing

Outsourcing is now critical for biotech companies aiming to...

How Modern Solutions Are Transforming Dental Care

Dentistry has come a long way from the days...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations.  Pizzie succeeds Dr. Steve Burton, who will remain with the company as President & Chief Scientific Officer.

Pizzie brings more than thirty years of commercial and operating experience in the life sciences and biotechnology sectors, most recently serving as CEO of Cambridge, UK based Horizon Discovery.  Prior to joining Horizon, Pizzie held a variety of senior leadership roles at companies including Pacific Biosciences, Genetix, GE Healthcare (Biacore) and Applied Biosystems.

“I am delighted to join the talented team at Astrea and to have the opportunity to lead this exceptional business. Together with Astrea’s management team, I will be focused on driving operational and commercial excellence while building out the infrastructure that will allow us to grow with our customers and the market,†said Pizzie. 

“We are thrilled to welcome Terry to Astrea and thank Steve for his many years of devoted leadership,†said Matt Gunnison, President of Gamma Biosciences. “Terry’s approach and track record of leading organizations is well aligned with our goal of establishing Astrea as a market leader in advanced therapy manufacturing while remaining true to the company’s legacy of scientific and technical excellence.â€

Latest stories

Related stories

New Tariff Announcement by Trump for Pharma, Patented Drugs

The announcement made by President Donald Trump that his...

U.S. Tariff Relief for EU and Japan on Pharmaceuticals

Donald Trump’s new tariffs when it comes to pharmaceutical...

Five key considerations for biotechs outsourcing biologics manufacturing

Outsourcing is now critical for biotech companies aiming to...

How Modern Solutions Are Transforming Dental Care

Dentistry has come a long way from the days...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »